Life Sciences Americas 2026: research cycle now open

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Life Sciences Americas 2026: research cycle now open

Copy of LS Research SMC.png

The Americas research cycle has commenced, so don't miss the opportunity to submit your work

Life Sciences Americas is excited to announce the launch of the 2026 research and awards cycle. The brand continues to recognise top firms, practitioners, and casework across the life sciences industry within the US, Canada, and Brazil.

The deadline for submissions is April 24 2026.

For detailed information about the rankings, including a detailed list of key dates, information on how-to-submit, research methodology and FAQs, click here.


Download & Complete the 2026 submission forms here


For awards-specific insights, including a list of potential award categories, please visit here.

Important Dates:

Submissions Open

Submissions Close

Shortlist Published

Gala Ceremony

Rankings Published

Feb 10 2026

April 24 2026

July 2026

Sept 10 2026

Sept 22 2026


All research submissions must be entered through our secure submissions platform. Submissions made in any other format or emailed will not be accepted due to GDPR compliance.

For questions about the research process, please contact Research Analyst Jose Martinez. For queries about business development and commercial opportunities, please contact George Reeves.

Please note that Life Sciences is a sister publication to and supported by Managing IP. It runs independently of the IPSTARS research.

more from across site and SHARED ros bottom lb

More from across our site

Examiner statistics could help patent prosecution practitioners tailor strategies, turning an area of high variability into a potential competitive advantage
The England and Wales High Court’s ruling in Accord v Novartis may not rewrite the law on plausibility, but it does signal a pragmatic approach that could provide greater certainty for life sciences innovators
Firms with established sports relationships and specialised expertise are well positioned to capture the market’s expanded pool of IP work
Gunjan Paharia discusses developing RIA, an AI platform built to draw on decades of institutional knowledge, support junior lawyers, and reshape how legal teams work
A strong Canadian business helped lift profits, but the IP service group's latest results underline the pressure facing its operations in Australia, New Zealand and parts of Asia
Wins in court have been key to the six-year-old firm’s growth, as one of its founders explains
The firm’s co-CEO discusses patent litigation, collaboration with overseas colleagues and the next generation of leaders
Two recent decisions demonstrate the courts’ creativity in cutting-edge IP disputes that tested their jurisdictional powers
Aditi Verma Thakur, managing partner at Aishani Partners, discusses 5 am wake-ups, working with high-performing professionals and staying calm under pressure
After more than three decades at Wilson Sonsini, Ian Edvalson explains why he moved to expand his life sciences transactional practice
Gift this article